Retrospective study evaluates visual improvements after vitrectomy in diabetic patients, highlighting the effect of IVB.
Key Points
To assess visual outcomes after pars plana vitrectomy in diabetic patients with vitreous hemorrhage, comparing diabetes types and the impact of preoperative intravitreal bevacizumab.
204 eyes from diabetic patients who underwent PPV for nonclearing vitreous hemorrhage analyzed retrospectively.
Patients categorized by diabetes type and preoperative IVB administration.
Visual acuity measured preoperatively and at 1 and 3 months post-surgery.
Postoperative improvement in best-corrected visual acuity was significant for both diabetes types (P < 0.001).
Type 2 diabetic patients showed greater median visual gain overall.
Type 1 diabetics receiving IVB demonstrated more pronounced improvement at 3 months, though not statistically significant.